MIAMI, Nov. 26 /PRNewswire/ -- Thomas K. Equels, President and Managing Director of the Equels Law Firm, has been elected to the board of directors for Hemispherx BioPharma, Inc. (Amex: HEB), a Philadelphia-based biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for the treatment of viral and immune-based disorders.
Equels' legal practice is devoted to litigation, with particular emphasis on civil racketeering, business torts and commercial matters. Prior to his board election, Equels served as Hemispherx BioPharma's litigation counsel.
For more than 25 years, Equels has represented national and state governments, and companies in the banking, insurance, aviation, pharmaceutical, construction and development industries. He has extensive experience in complex litigation matters including:
-- Obtained a $26.8 million judgment in 2008 in a breach of contract action against Bear Stearns, for the Delaware Insurance Commissioner, related to an insolvent insurance company. -- Obtained a $15 million judgment in 2005 against boy band guru Lou Pearlman of Trans Continental Records, Inc. -- Obtained a $44 million judgment against Manuel Noriega for public money he misappropriated from the Republic of Panama. -- Recovered more than $100 million misappropriated and money laundered overseas by former insiders of a now defunct insurance company being liquidated by the State of Delaware's Insurance Commissioner. -- Obtained and collected a $10.6 million judgment against the FDIC for breach of contract involving a client's purchase of a national mortgage company owned by a failed savings and loan. -- Prosecuted a bank fraud claim against an international lender, which resulted in a jury aw
|SOURCE Equels Law Firm|
Copyright©2008 PR Newswire.
All rights reserved